Premium listings
  • 3rd International Conference on Transcriptomics

    3rd International Conference on Transcriptomics

    Life Sciences Bangkok (Bangkok) March 13, 2017 Check with publisher

    Conference Series has been instrumental in conducting international Biochemistry meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Philadelphia, Orlando ...

  • Developing drugs for the treatment of neurodegenerative diseases

    Developing drugs for the treatment of neurodegenerative diseases

    PhD Studentships Liverpool December 3, 2016 Check with publisher

    Ageing is arguably the major biomedical challenge of the 21st century with the incidence of age-related diseases, and neurodegenerative diseases in particular, expected to increase dramatically in the coming decades. In model organisms, the process o...

  • Characterization and functional analysis of a novel cancer-associated gene

    Characterization and functional analysis of a novel cancer-associated gene

    PhD Studentships Liverpool May 15, 2016 Check with publisher

    Genes involved in common biological processes and diseases tend to be co-expressed. Therefore, genes co-expressed with known disease-associated genes will help identify new candidates for further studies. Our lab has recently developed a co-expressio...

  • Festival of Genomics London

    Festival of Genomics London

    Medical Sciences London (London) July 6, 2016 Check with publisher

    It's the return of the Festival. Last January 832 people gathered at the ExCeL London. There they found a room full of colleagues, new and old, all with the same mission: using genomics to improve healthcare. There was music, bubbles filled with DNA,...

  • Expertise in genomics and transcriptomics

    Expertise in genomics and transcriptomics

    Data Analysis - Analytics August 24, 2015 Check with publisher

    I lead the Integrative Genomics of Ageing Group (http://pcwww.liv.ac.uk/~aging/), and I have extensive experience in data analysis and integration of multidimensional data. Although my lab’s research integrates different strategies, its focal point i...

  • DrugAge database of compounds that increase lifespan

    DrugAge database of compounds that increase lifespan

    Biomedical Sciences Liverpool August 24, 2015 Check with publisher

    We're starting a new database of drugs and compounds (including natural products) with anti-ageing properties that extend longevity in model organisms. The database will be called DrugAge, and although we have some data already, we are looking for da...

Listings
  • Anti-CD79B (Polatuzumab)-Mc-VC-PABC-MMAE ADC

    Anti-CD79B (Polatuzumab)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody conjugated via a Mc-VC-PABC linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within th...

  • Anti-CD79B (Polatuzumab)-VC-MMAE ADC

    Anti-CD79B (Polatuzumab)-VC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody conjugated via a VC linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, ...

  • Anti-CD79b (clone 10D10)-MCC-DM1 ADC

    Anti-CD79b (clone 10D10)-MCC-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone 10D10) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-CD79b (SN8)-Mc-MMAF ADC

    Anti-CD79b (SN8)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce...

  • Anti-CD79b (SN8)-Mc-VC-PABC-MMAE ADC

    Anti-CD79b (SN8)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...

  • Anti-CD79b (SN8)-MCC-DM1 ADC

    Anti-CD79b (SN8)-MCC-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-CD79b (SN8)-SPP-DM1 ADC

    Anti-CD79b (SN8)-SPP-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a SPP linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone MA79b ) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

  • Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone MA79b ) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

  • Anti-CD79b (clone ch10D10)-Mc-VC-PABC-MMAE ADC

    Anti-CD79b (clone ch10D10)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated end...

  • Anti-CD79b (clone ch10D10)-BMPEO-DM1 ADC

    Anti-CD79b (clone ch10D10)-BMPEO-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a BMPEO linker to DM1. The DM1 is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

    Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis...